Dlh Holdings Corp. DLHC
We take great care to ensure that the data presented and summarized in this overview for DLH Holdings Corp. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding DLHC
View all-
Wynnefield Capital Inc New York, NY3.68MShares$31.8 Million20.93% of portfolio
-
Minerva Advisors LLC Bala Cynwyd, PA636KShares$5.49 Million3.99% of portfolio
-
Punch & Associates Investment Management, Inc. Edina, MN567KShares$4.89 Million0.32% of portfolio
-
Vanguard Group Inc Valley Forge, PA566KShares$4.88 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT412KShares$3.55 Million0.02% of portfolio
-
Black Rock Inc. New York, NY352KShares$3.04 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny263KShares$2.27 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX258KShares$2.23 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA227KShares$1.96 Million0.0% of portfolio
-
Perritt Capital Management Inc Chicago, IL218KShares$1.88 Million1.11% of portfolio
Latest Institutional Activity in DLHC
Top Purchases
Top Sells
About DLHC
DLH Holdings Corp. provides technology-enabled business process outsourcing, program management solutions, and public health research and analytics services in the United States. The company offers defense and veterans' health solutions, including healthcare, technology, and logistics solutions to the VA, Defense Health Agency, Tele-medicine and Advanced Technology Research Center, Navy Bureau of Medicine and Surgery, and the Army Medical Research and Material Command. It also provides a range of human services and solutions, which consists of monitoring and evaluation, electronic medical records migration, data collection and management, and nutritional and social health assessments; and IT system architecture design, migration plan, and ongoing maintenance services. In addition, the company offers public health and life sciences services, such as clinical trials, epidemiology studies, and disease prevention; and health promotion to underserved and at-risk communities through development of strategic communication campaigns, research on emerging trends, health informatics analyses, and application of best practices. It primarily serves the federal health services market. The company was formerly known as TeamStaff, Inc. and changed its name to DLH Holdings Corp. in June 2012. DLH Holdings Corp. was incorporated in 1969 and is headquartered in Atlanta, Georgia.
Insider Transactions at DLHC
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 01
2024
|
Austin J. Yerks Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,941
+6.56%
|
-
|
|
Oct 01
2024
|
Frederick Gerald Wasserman Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,910
+4.65%
|
-
|
|
Oct 01
2024
|
Martin J Delaney Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,941
+35.93%
|
-
|
|
Oct 01
2024
|
Stephen Zelkowicz Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,941
+19.09%
|
-
|
|
Oct 01
2024
|
Frances M Murphy Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,941
+8.99%
|
-
|
|
Oct 01
2024
|
Judith L Bjornaas Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,941
+35.93%
|
-
|
|
Oct 01
2024
|
Elder Granger Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,941
+7.14%
|
-
|
|
Sep 20
2024
|
Kathryn M. John Bull Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
78,240
-13.11%
|
$704,160
$9.78 P/Share
|
|
Sep 20
2024
|
Kathryn M. John Bull Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
200,000
+25.1%
|
$200,000
$1.95 P/Share
|
|
Jul 18
2024
|
Martin J Delaney Director |
BUY
Bona fide gift
|
Indirect |
191,695
+49.16%
|
-
|
|
Jul 18
2024
|
Martin J Delaney Director |
SELL
Bona fide gift
|
Direct |
191,695
-95.72%
|
-
|
|
May 09
2024
|
Martin J Delaney Director |
BUY
Bona fide gift
|
Indirect |
6,544
+49.92%
|
-
|
|
May 09
2024
|
Martin J Delaney Director |
SELL
Bona fide gift
|
Direct |
6,544
-3.16%
|
-
|
|
Feb 20
2024
|
Jeanine M. Christian Pres. Pub. Health & Sci Rs |
SELL
Open market or private sale
|
Direct |
11,985
-100.0%
|
$191,760
$16.21 P/Share
|
|
Feb 16
2024
|
Jeanine M. Christian Pres. Pub. Health & Sci Rs |
SELL
Open market or private sale
|
Direct |
9,027
-42.96%
|
$135,405
$15.92 P/Share
|
|
Feb 15
2024
|
Jeanine M. Christian Pres. Pub. Health & Sci Rs |
SELL
Open market or private sale
|
Direct |
13
-0.06%
|
$208
$16.0 P/Share
|
|
Feb 14
2024
|
Jeanine M. Christian Pres. Pub. Health & Sci Rs |
SELL
Open market or private sale
|
Direct |
100
-0.47%
|
$1,600
$16.75 P/Share
|
|
Feb 13
2024
|
Jeanine M. Christian Pres. Pub. Health & Sci Rs |
SELL
Open market or private sale
|
Direct |
3,826
-15.33%
|
$61,216
$16.99 P/Share
|
|
Jan 19
2024
|
Jeanine M. Christian Pres. Pub. Health & Sci Rs |
SELL
Payment of exercise price or tax liability
|
Direct |
50,049
-66.73%
|
$800,784
$16.29 P/Share
|
|
Jan 19
2024
|
Jeanine M. Christian Pres. Pub. Health & Sci Rs |
BUY
Exercise of conversion of derivative security
|
Direct |
75,000
+50.0%
|
$600,000
$8.02 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 163K shares |
|---|---|
| Bona fide gift | 198K shares |
| Exercise of conversion of derivative security | 275K shares |
| Bona fide gift | 198K shares |
|---|---|
| Payment of exercise price or tax liability | 128K shares |
| Open market or private sale | 25K shares |